• Kathryn Griffiths, Mariam Molokhia, and Kate Bramham.
• King's College London.
• Br J Gen Pract. 2023 Jul 1; 73 (suppl 1).

BackgroundChronic kidney disease (CKD) is prevalent in the UK, associated with significant mortality and morbidity, and disproportionately affects minority ethnic groups. The most common causes for CKD are diabetes and hypertension. An estimated glomerular function (eGFR) blood test and an albumin creatinine ratio (uACR) urine test can be used to assess the level of CKD and predict the risk of adverse outcomes such as cardiovascular disease, end stage renal failure, and death. However, UK National CKD audit data suggest that only 30% of those with hypertension have a recorded uACR. Our quality improvement project working with community stakeholders and Healthy.io digital enterprise will evaluate the feasibility of uACR self-testing in the community.AimTo promote uACR testing using smartphone home self-testing kits (Heathy.io) to improve the early diagnosis of CKD in individuals with hypertension.MethodIndividuals with hypertension in three GP practices in ethnically diverse areas in London will be invited to use a home self-testing uACR kit. Healthy.io (providers of kit) will complete patient enrolment and make one attempt to contact non-responders. Non-responders will be offered peer support to assist engagement. Qualitative data will be sought regarding the acceptability of the test for both clinicians and patients.ResultsWe will recruit three practices in South London and mail 200 digital urine testing kits. Uptake and results will be presented.ConclusionImproving equity in uACR testing through quality improvement tools can deliver a sustainable project for improving patient renal care. Leveraging innovative methods provides the potential for effective, equitable, and efficient services.© British Journal of General Practice 2023.

25 keywords...

hide…